Search results
Sarepta Gains as FDA Official Overrules Staff to Approve Therapy
Bloomberg via Yahoo Finance· 11 hours ago(Bloomberg) -- A top US Food and Drug Administration official overrode reviewers to give broad...
Intra-Cellular Therapies (NASDAQ:ITCI) PT Raised to $94.00 at Needham & Company LLC
ETF DAILY NEWS· 2 days agoThe brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on ITCI. Bank of America increased their target < ...
Taysha Gene Therapies (NASDAQ:TSHA) Given Overweight Rating at Cantor Fitzgerald
ETF DAILY NEWS· 2 days agoCantor Fitzgerald’s target price suggests a potential upside of 135.69% from the company’s current price. JMP Securities restated a “market outperform” ...
OS Therapies Inc. Prices IPO at $4.00 Per Share (OSTX)
ETF DAILY NEWS· 6 days agoOS Therapies Inc. (OSTX) plans to raise $8 million in an initial public offering on Thursday, June 20th, IPO Scoop reports. The company will be issuing 2,000,000 shares at a price< ...
This DTC Home Brand Sells the Most Gorgeous Quiet Luxury-Inspired Finds
Apartment Therapy via Yahoo News· 6 hours agoIts sturdy construction features a thick headboard that wraps around the sides a bit — a feature...
Sarepta Skyrockets After FDA Signs Off On Duchenne Gene Therapy
Investor's Business Daily· 16 hours agoLast year, the FDA granted the Sarepta Therapeutics (SRPT) gene therapy, dubbed Elevidys, an accelerated approval for children ages 4 and 5 with Duchenne muscular dystrophy ...
Health Care Roundup: Market Talk
The Wall Street Journal· 6 hours agoFind insight on Zealand Pharma’s petrelintide shot , Sarepta Therapeutics, EssilorLuxottica, and more in the latest Market Talks covering the Health Care...
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.1%
ETF DAILY NEWS· 6 days agoTaysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) traded down 4.1% on Friday . The company traded as low as $3.95 and last traded at $4.00. 191,240 shares were traded during trading ...
S&P 500 Trading Volume Spikes at Wall Street Close: Markets Wrap
Bloomberg via Yahoo Finance· 6 hours ago(Bloomberg) -- Wall Street’s massive expiration of options not only left stock traders more...
Sarepta surges as investors cheer expanded use of gene therapy
WSAU Wausau· 15 hours ago(Reuters) - Sarepta Therapeutics shares surged about 36% in premarket trading on Friday as an expanded use approval opened up a bigger market in the U.S. for its gene therapy